SEC Form 4 · accession 0001434647-26-000057
ZEVRA THERAPEUTICS, INC. · ZVRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rahsaan Thompson
Officer — Chief Legal & Compliance
Period of report
Jun 21, 2026
Accepted (ET)
Jun 23, 2026 · 4:16 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001434647
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 21, 2026 | M | 66,667 | — | A | 114,792 | D | |
| Common StockF3 | Jun 22, 2026 | S | 34,557 | $12.6835 | D | 80,235 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F4 | — | Jun 21, 2026 | M | 66,667 | D | — | — | Common Stock | 66,667 | 66,667 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- F2Adoption date of referenced 10b5-1(c) plan is: 01-08-2026.
- F3This transaction was executed in multiple trades at prices ranging from $12.53 to $13.19. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4The first and second tranches of the restricted stock units vested and settled on June 21, 2025 and June 21, 2026, respectively, and the remaining tranche of the restricted stock units will vest and settle on the next anniversary thereafter, subject to the Reporting person's continued service through such vesting date.